Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-06-05
2007-06-05
Habte, Kahsay (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S116000, C544S237000, C514S234500
Reexamination Certificate
active
11233311
ABSTRACT:
Compounds of formula Itheir pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates are disclosed. Also disclosed are methods for the preparation of the above-mentioned compounds, pharmaceutical compositions containing them, as well as the use of the above-mentioned compounds in the treatment, control or prevention of illnesses such as cancer.
REFERENCES:
patent: 6207401 (2001-03-01), Plowman et al.
patent: 1 051 500 (2000-11-01), None
patent: WO 95/19169 (1995-07-01), None
patent: WO 95/23141 (1995-08-01), None
patent: WO 97/022702 (1997-06-01), None
patent: WO 97/42187 (1997-11-01), None
patent: WO 99/06396 (1999-02-01), None
patent: WO 00/05219 (2000-02-01), None
patent: WO 00/44728 (2000-08-01), None
patent: WO 00/47212 (2000-08-01), None
patent: WO 01/21594 (2001-03-01), None
patent: WO 01/21595 (2001-03-01), None
patent: WO 01/21596 (2001-03-01), None
patent: WO 01/21597 (2001-03-01), None
patent: WO 01/55116 (2001-08-01), None
patent: WO 01/77085 (2001-10-01), None
patent: WO 02/22601 (2002-03-01), None
patent: WO 02/22602 (2002-03-01), None
patent: WO 02/22603 (2002-03-01), None
patent: WO 02/22604 (2002-03-01), None
patent: WO 02/22605 (2002-03-01), None
patent: WO 02/22606 (2002-03-01), None
patent: WO 02/22607 (2002-03-01), None
patent: WO 02/22608 (2002-06-01), None
patent: WO 02/50065 (2002-06-01), None
patent: WO 02/50066 (2002-06-01), None
patent: WO 02/057259 (2002-07-01), None
patent: WO 02/059111 (2002-08-01), None
patent: WO 02/059112 (2002-08-01), None
patent: WO 02/062789 (2002-08-01), None
patent: WO 02/066461 (2002-08-01), None
patent: WO 02/068415 (2002-09-01), None
patent: WO 02/96905 (2002-12-01), None
patent: WO 03/015785 (2003-02-01), None
patent: WO 03/055491 (2003-07-01), None
patent: WO 03/077921 (2003-09-01), None
patent: WO 03/078423 (2003-09-01), None
patent: WO 03/078426 (2003-09-01), None
patent: WO 03/078427 (2003-09-01), None
patent: WO 04/000833 (2003-12-01), None
patent: WO 04/005283 (2004-01-01), None
Adams, R.R., et al, Trends Cell Biol. 11 (2001) 49-54.
Bischoff, J.R. and Plowman, G.D., Trends Cell Biol. 9 (1999) 454-459.
Giet, R., and Prigent, C., J. Cell Sci. 112 (1999) 3591-3601.
Harrington, E.A. et al, Nat. Med. 10 (2004) 262-267.
Hunter, T., Cell 50 (1987) 823-829.
Isola, J.J. et al., Am. J. Pathol. 147 (1995) 905-911.
Nigg, E.A., Nat. Rev. Mol. cell Biol. 2 (2001) 21-32.
Sen, S. et al, J. Natl. Cancer Inst. 94 (2002) 1320-1329.
Boyd Edward
Brookfield Frederick
Georges Guy
Goller Bernhard
Huensch Sabine
Habte Kahsay
Hoffman-La Roche Inc.
Johnson George W.
Rocha-Tramaloni Patricia S.
LandOfFree
Phthalazinone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phthalazinone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phthalazinone derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3835420